Intravenous administration of amlodipine
Pro Research Analysisby 
Searched over 200M research papers
Intravenous Amlodipine: Pharmacokinetics and Hemodynamic Effects
Pharmacokinetics of Intravenous Amlodipine
Intravenous administration of amlodipine in healthy volunteers shows a long plasma half-life of about 34 hours, a low clearance rate, and a large volume of distribution, indicating that the drug stays in the body for an extended period and is widely distributed in tissues. The systemic availability of amlodipine is higher with intravenous administration compared to oral dosing, as oral administration is affected by first-pass metabolism, resulting in a bioavailability of about 64–79% in both humans and animal models 68.
Hemodynamic and Antianginal Effects
Intravenous amlodipine has significant vasodilatory effects. In patients with stable angina, IV amlodipine increases heart rate slightly, reduces systemic vascular resistance, and lowers mean arterial pressure. Importantly, it increases the time to onset of angina during atrial pacing and reduces ST-segment changes, indicating improved myocardial oxygen supply and reduced ischemia. These effects occur without negative impacts on cardiac output or contractility, making IV amlodipine effective for increasing the anginal threshold and reducing myocardial oxygen consumption 23.
Coronary Vasodilation
Studies in patients with normal coronary arteries show that intravenous amlodipine produces strong coronary vasodilation, especially at the microcirculatory level. After administration, both coronary flow velocity and cross-sectional area increase, leading to a substantial rise in coronary blood flow. The vasodilatory effect of IV amlodipine is progressive over time and is significant compared to baseline measurements .
Intravenous Amlodipine in Overdose and Toxicity Management
Clinical Presentation and Standard Interventions
Amlodipine overdose can cause severe hypotension and shock due to profound peripheral vasodilation. Standard treatments include gastrointestinal decontamination, intravenous fluids, calcium infusions, vasopressors, hyperinsulinemic euglycemia, and glucagon. However, these interventions may not always be effective in reversing shock in severe cases 159.
Use of Intravenous Lipid Emulsion (ILE) Therapy
Intravenous lipid emulsion has been explored as a rescue therapy for amlodipine overdose. Case reports show that ILE can stabilize hemodynamics and allow for the reduction of vasopressor support in some patients with life-threatening shock after amlodipine overdose 15. However, the effectiveness of ILE is inconsistent, especially in cases of very high-dose amlodipine ingestion, where it may not improve hemodynamics and additional interventions like plasmapheresis may be required .
Other Advanced Therapies
In cases of combined amlodipine and beta-blocker overdose, aggressive management with intravenous calcium, hyperinsulinemic euglycemia therapy, and continuous veno-venous hemodialysis has been shown to improve outcomes and reverse cardiovascular collapse .
Experimental Models
Animal studies using intravenous amlodipine have helped establish models for studying amlodipine-induced shock and testing new interventions. These models confirm the drug’s potential to cause rapid and severe toxicity when administered intravenously at high doses .
Conclusion
Intravenous amlodipine is characterized by a long half-life, high tissue distribution, and strong vasodilatory effects, both systemically and in the coronary circulation. While it is effective for increasing anginal threshold and coronary blood flow, overdose can result in life-threatening shock that is difficult to manage. Intravenous lipid emulsion and other advanced therapies may be considered in severe toxicity, but their effectiveness can vary, especially in massive overdoses.
Sources and full results
Most relevant research papers on this topic